ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,076Medicare Part D Prescriptions Filled, Including Refills

Rank: 48 out of 2456

$1.28M Total Retail Price of All Prescriptions

Rank: 21 out of 2456

938 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

14% of this provider’s 938 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 15,834 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$80 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
AMLODIPINE BESYLATE 1,166 1,131 1 5
SIMVASTATIN 968 945 2 2
LISINOPRIL 579 575 3 1
METOPROLOL SUCCINATE 563 560 4 13
RANITIDINE HCL 561 551 5 31
OMEPRAZOLE 525 518 6 3
ALENDRONATE SODIUM 400 396 7 19
ATORVASTATIN CALCIUM 337 337 8 12
FUROSEMIDE 336 336 9 8
LEVOTHYROXINE SODIUM 296 289 10 4
LOSARTAN POTASSIUM 292 279 11 18
METFORMIN HCL 291 271 12 11
GLIPIZIDE ER 273 273 13 89
TRIAMCINOLONE ACETONIDE 270 269 14 131
METOPROLOL TARTRATE 269 269 15 10
WARFARIN SODIUM 261 261 16 9
ATENOLOL 260 257 17 6
TERAZOSIN HCL 249 249 18 76
CLOBETASOL PROPIONATE 247 246 19 208
DIOVAN 240 240 20 26
ACTOS 228 225 21 124
ZOLPIDEM TARTRATE 227 227 22 28
EVISTA 220 220 23 143
ACETAMINOPHEN-CODEINE 214 207 S3 24 106
ISOSORBIDE MONONITRATE ER 167 167 25 48
GLIPIZIDE XL 165 165 26 168
TRAMADOL HCL 158 158 27 24
COLCRYS 153 153 28 171
FINASTERIDE 147 147 29 66
HYDROCHLOROTHIAZIDE 147 146 29 7
ALLOPURINOL 143 143 31 27
PROAIR HFA 136 136 32 22
TAMSULOSIN HCL 131 131 33 32
LIPITOR 130 130 34 63
GLIPIZIDE 125 125 35 46
NIFEDIPINE ER 124 119 36 61
SPIRIVA 118 118 37 43
QUINAPRIL HCL 115 115 38 110
PRAVASTATIN SODIUM 111 111 39 15
NAPROXEN 103 103 40 109
AMOXICILLIN 100 95 41 191
DIOVAN HCT 98 98 42 139
PIOGLITAZONE HCL 95 94 R 43 245
AZITHROMYCIN 95 94 43 60
FLUTICASONE PROPIONATE 94 92 45 30
POTASSIUM CHLORIDE 90 90 46 33
NIASPAN 89 85 47 181
AMMONIUM LACTATE 89 89 47 265
LOVASTATIN 84 81 49 34
BENICAR 83 83 50 160
ADVAIR DISKUS 82 82 51 36
MECLIZINE HCL 82 81 51 107
LOSARTAN-HYDROCHLOROTHIAZIDE 75 70 53 117
PANTOPRAZOLE SODIUM 73 73 54 37
LIDODERM 72 72 55 58
ZETIA 72 72 55 86
FLOVENT HFA 63 63 57 104
VERAPAMIL ER 61 56 58 91
NEXIUM 61 61 58 80
DONEPEZIL HCL 58 58 60 23
DIGOXIN 58 58 60 49
MIRTAZAPINE 54 54 62 29
CRESTOR 53 53 63 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 49 63 41
CARVEDILOL 52 52 65 54
PEN NEEDLE 51 51 66 150
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 10, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.